维普期刊资源整合服务平台（V6.5）

29篇 您的检索式：作者名="YOOD RA"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	The lag time between onset of symptoms and diagnosis of rheumatoid arthritis显示文摘	Felson DT Yood RA	1994	Arthritis Rheum1994，37，：	1
2	Identifying unrecognized peripheral arterial disease among asymptomatic patients in the primary care setting显示文摘	Doubeni CA Yood RA Emani S	2006	Angiology2006，57，2：	1
3	Serum procalcitonin in systemic autoimmune diseases-where are we now显示文摘	Buhaescu I Yood RA Izzedine H		0，，02：	1
4	Serum procalcitonin in systemic autoimmune diseases-where are we now显示文摘	Buhaescu I Yood RA Izzedine H	2010	Semin Arthritis Rheum2010，40，2：	1
5	Serum procalcitonin in systemicautoimmune diseases-where are we now显示文摘	Buhaecu I Yood RA Izzedine H	2010	Semin Arthritis Rheum2010，40，2：	1
6	Prevention of glucocorticoid-induced osteoporosis:experience in a managed care setting显示文摘	Yood RA Harrold LR Fish L	2011	Arch Intern Med2011，，161：	1
7	Patient decision to initiate ther-apy for osteoporosis :the influence of knowledge and beliefs显示文摘	Yood RA Mazor KM Andrade SE	2008	J GenIntern Med’2008，23，11：	1
8	Efficacy and tolerability ofpegloticase for the treatment of chronic gout in patients refractory toconventional treatments显示文摘	Sundy JS Baraf HSB Yood RA	2011	JAMA2011，306，5：	1
9	Efficacy and tolerability of pe- gloticase for the treatment of chronic gout in patients refractory to conventional treatment : two randomized controlled trims 显示文摘	Sundy JS Baraf HS Yood RA	2011	JAMA2011，306，：	1
10	Prevention of glucocorticoid - induced osteoporosis: experience in a managed care setting显示文摘	Yood RA Harrold LR Fish L	2001	Arch Inter Med2001，161，10：	1
11	Prevention of glucocorticoidinduced osteoporosis: experience in a managed care setting显示文摘	Yood RA Harrold LR Fish L	2001	Arch Inter Med2001，161，10：	1
12	The lag time between onset of symptoms and diagnosis of rheumtoid arthritis 显示文摘	Chan KMA Felson DT Yood RA	1993	Arthritis Rheum1993，37，6：	1
13	Guidelines for the management of rheumatoid arthritis:2002 update显示文摘	Yood RA	2002	Arthritis Rheum2002，46，2：	1
14	Sex differences in gout epidemiology:evaluation and treatment显示文摘	Harrold LR Yood RA Mikuls TR		0，，10：	1
15	Consequences of poor compliance with bisphosphonates显示文摘	Briesacher BA Andrade SE Yood RA Kahler KH	2007	Bone2007，41，：	1
16	Serum procalcitonin in systemic autoimmune diseases-where are we now 显示文摘	Buhaescu I Yood RA Izzedine I4	2010	Semin Arthritis Rheum2010，40，2：	1
17	Efficacy and tolera- bility of pegloticase for the treatment of chronic gout in pa- tients refractory to conventional treatments显示文摘	Sundy JS Baraf HSB Yood RA	2011	JAMA2011，306，5：	1
18	Efficacy and tolerability of pegloticase for the treatment of chronic gout in patients refractory to conventional treatment:two randomized controlled trials显示文摘	SUNDY JS BARAF HS YOOD RA	2011	JAMA2011，306，7：	1
19	Effect of pegloticase on renal function in patients with chronic kidney disease : a post hoc subgroup analysis of 2 randomized, placebo-controlled, phase 3 clinical trials 显示文摘	Yood RA Otter'/ FD Irish W	2014	BMC ResNotes2014，7，：	1
20	The lag time between on set of symptoms and diagnosis of rheumatoid arthritis显示文摘	Chan Kma Felson DT Yood RA	1993	Arthritis Rheum1993，37，：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示